Literature DB >> 8021519

Expansion of selected V delta 1+ gamma delta T cells in systemic sclerosis patients.

V V Yurovsky1, P A Sutton, D H Schulze, F M Wigley, R A Wise, R F Howard, B White.   

Abstract

We have previously shown an increased percentage of gamma delta T cells expressing the TCR V delta 1 gene segment in the peripheral blood and bronchoalveolar lavage fluid of patients with systemic sclerosis (SSC). To estimate clonality of these V delta 1+ T cells, the diversity of V delta 1 junctional regions (V-D-J) was examined using a reverse transcriptase-PCR to amplify TCR delta-chain transcripts isolated from PBMC, lung, esophagus, stomach, or skin of patients and controls. Limited diversity of V delta 1-J delta junctional regions in SSC patients was demonstrated by comparing the size distribution of PCR-amplified junctional region cDNA from patients with that of controls. Sequence analyses confirmed that V delta 1-J delta junctional regions from the blood of SSc patients had less diversity than those from controls, in that a significantly higher proportion of sequences were repeated in patients (54.4 vs 19.4% in controls). Evidence for selection of the V delta 1+ T cells in the tissues of SSC patients came from the findings that the same V delta 1-J delta junctional sequences persisted in an individual patient over time and that identical junctional sequences were isolated from multiple sites. Analysis of deduced amino acid sequences revealed two clusters of similarities among the junctional regions from patients. These data suggest that expansion of V delta 1+ gamma delta T cells may be Ag driven in SSC patients.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8021519

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  14 in total

Review 1.  Bone marrow transplantation in the treatment of systemic sclerosis.

Authors:  F Viganego; R Nash; D E Furst
Journal:  Curr Rheumatol Rep       Date:  2000-12       Impact factor: 4.592

Review 2.  T lymphocyte and fibroblast interactions: the case of skin involvement in systemic sclerosis and other examples.

Authors:  C Chizzolini
Journal:  Springer Semin Immunopathol       Date:  1999

3.  Circulating gamma/delta T lymphocytes from systemic sclerosis (SSc) patients display a T helper (Th) 1 polarization.

Authors:  R Giacomelli; P Cipriani; A Fulminis; G Barattelli; M Matucci-Cerinic; S D'Alò; G Cifone; G Tonietti
Journal:  Clin Exp Immunol       Date:  2001-08       Impact factor: 4.330

4.  Phase I/II trial of autologous stem cell transplantation in systemic sclerosis: procedure related mortality and impact on skin disease.

Authors:  M Binks; J R Passweg; D Furst; P McSweeney; K Sullivan; C Besenthal; J Finke; H H Peter; J van Laar; F C Breedveld; W E Fibbe; D Farge; E Gluckman; F Locatelli; A Martini; F van den Hoogen; L van de Putte; A V Schattenberg; R Arnold; P A Bacon; P Emery; I Espigado; B Hertenstein; F Hiepe; A Kashyap; I Kötter; A Marmont; A Martinez; M J Pascual; A Gratwohl; H G Prentice; C Black; A Tyndall
Journal:  Ann Rheum Dis       Date:  2001-06       Impact factor: 19.103

5.  Peripheral T lymphocytes from patients with early systemic sclerosis co-cultured with autologous fibroblasts undergo an oligoclonal expansion similar to that occurring in the skin.

Authors:  Raffaele De Palma; Francesco Del Galdo; Salvatore Lupoli; Paolo Altucci; Gianfranco Abbate; Gabriele Valentini
Journal:  Clin Exp Immunol       Date:  2006-04       Impact factor: 4.330

Review 6.  Cellular immunity in osteoarthritis: novel concepts for an old disease.

Authors:  S N Liossis; G C Tsokos
Journal:  Clin Diagn Lab Immunol       Date:  1998-07

7.  Lymphadenopathy driven by TCR-Vγ8Vδ1 T-cell expansion in FAS-related autoimmune lymphoproliferative syndrome.

Authors:  Stefano Vavassori; Jacob D Galson; Johannes Trück; Anke van den Berg; Rienk Y J Tamminga; Aude Magerus-Chatinet; Olivier Pellé; Ulrike Camenisch Gross; Ewerton Marques Maggio; Seraina Prader; Lennart Opitz; Ursina Nüesch; Andrea Mauracher; Benjamin Volkmer; Oliver Speer; Luzia Suda; Benno Röthlisberger; Dieter Robert Zimmermann; Rouven Müller; Arjan Diepstra; Lydia Visser; Eugenia Haralambieva; Bénédicte Neven; Frédéric Rieux-Laucat; Jana Pachlopnik Schmid
Journal:  Blood Adv       Date:  2017-06-22

Review 8.  Scleroderma lung: pathogenesis, evaluation and current therapy.

Authors:  Jacob M van Laar; Jan Stolk; Alan Tyndall
Journal:  Drugs       Date:  2007       Impact factor: 9.546

9.  Gamma delta T cell receptor gene expression by muscle-infiltrating lymphocytes in the idiopathic inflammatory myopathies.

Authors:  T P O'Hanlon; W A Messersmith; M C Dalakas; P H Plotz; F W Miller
Journal:  Clin Exp Immunol       Date:  1995-06       Impact factor: 4.330

10.  Circulating TCR gammadelta cells in the patients with systemic lupus erythematosus.

Authors:  E Robak; J Z Błoński; J Bartkowiak; H Niewiadomska; A Sysa-Jedrzejowska; T Robak
Journal:  Mediators Inflamm       Date:  1999       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.